New hope for advanced HER-2 cancers: drug combo tested in real-world study
Disease control
Ongoing
This study looks at a drug called Trastuzumab Rezetecan, given alone or with other treatments, for people with advanced solid tumors that have a protein called HER-2. The main goal is to see how safe the drug is and how well it controls the cancer. About 30 adults whose cancer ha…
Sponsor: Lixiaoling • Aim: Disease control
Last updated May 22, 2026 13:55 UTC